Homocysteine, renal function, and risk of cardiovascular disease.

Homocysteine, renal function, and risk of cardiovascular disease.

BACKGROUND: Patients with renal impairment have markedly elevated homocysteine levels and are at particularly high risk of ischemic heart disease (IHD) and stroke, but the relevance of elevated homocysteine levels in this population is uncertain. METHODS: We examined the association with IHD from a...

Полное описание

Библиографические подробности
Главные авторы:	Clarke, R, Lewington, S, Landray, M
Формат:	Journal article
Язык:	English
Опубликовано:	2003

Схожие документы

Homocysteine and risk of cardiovascular disease and venous thrombosis
по: Clarke, R, и др.
Опубликовано: (2003)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
по: Clarke, R, и др.
Опубликовано: (2007)

Homocysteine and coronary heart disease.
по: Clarke, R, и др.
Опубликовано: (2002)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
по: Clarke, R
Опубликовано: (2011)

Homocysteine and prediction of coronary heart disease and stroke
по: Clarke, R, и др.
Опубликовано: (2003)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
по: Clarke, R, и др.
Опубликовано: (2001)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
по: Clarke, R, и др.
Опубликовано: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
по: Clarke, R, и др.
Опубликовано: (2011)

Homocysteine and cardiovascular disease. Overview.
по: Clarke, R
Опубликовано: (1998)

Renal function: an emerging risk factor for cardiovascular disease?
по: Landray, M, и др.
Опубликовано: (2001)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
по: Clarke, R, и др.
Опубликовано: (2005)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
по: Clarke, R
Опубликовано: (2009)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
по: Den Heijer, M, и др.
Опубликовано: (2005)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
по: Clarke, R
Опубликовано: (2002)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
по: Clarke, R, и др.
Опубликовано: (2001)

Homocysteine and cardiovascular disease
по: p yavari
Опубликовано: (2000-06-01)

Homocysteine and cardiovascular disease
Опубликовано: (2000-05-01)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
по: Clarke, R, и др.
Опубликовано: (2007)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
по: Lewington, S, и др.
Опубликовано: (2005)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
по: Lewington, S, и др.
Опубликовано: (2005)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
по: Jan Filipovský
Опубликовано: (2007-08-01)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
по: Clarke, R, и др.
Опубликовано: (2000)

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
по: Andrew H Ford, и др.
Опубликовано: (2012-01-01)

Homocysteine, B vitamins, and cardiovascular disease
по: Refsum, H, и др.
Опубликовано: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
по: Refsum, H, и др.
Опубликовано: (2006)

Homocysteine, B vitamins, and the risk of dementia.
по: Clarke, R
Опубликовано: (2007)

Homocysteine, the kidney, and vascular disease.
по: Haynes, R, и др.
Опубликовано: (2012)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
по: Danesh, J, и др.
Опубликовано: (1998)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
по: Haynes, R, и др.
Опубликовано: (2012)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
по: Ueland, P, и др.
Опубликовано: (2007)

Elevated homocysteine and differential risks of the renal function decline in hypertensive patients
по: Chunlei Liu, и др.
Опубликовано: (2020-08-01)

Uncontrolled hypertension and risk of cardiovascular mortality in China-reply
по: Lewington, S, и др.
Опубликовано: (2016)

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
по: Marcello Ciaccio, и др.
Опубликовано: (2008-03-01)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
по: Clarke, R, и др.
Опубликовано: (1998)

Homocysteine-lowering trials for prevention of heart disease and stroke.
по: Clarke, R
Опубликовано: (2005)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
по: Holman, R, и др.
Опубликовано: (2001)

Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
по: Swiss Medical Weekly
Опубликовано: (2006-12-01)

Homocysteine and malondialdeyde (MDA) levels associated with the occurrence of cardiovascular disease (CVD) in chronic renal failure (CRF) in Malaysia.
по: Arab, Shahin, и др.
Опубликовано: (2011)

Which cardiovascular risk factors matter in chronic kidney disease?
по: Baigent, C, и др.
Опубликовано: (2007)

Detecting homocysteine in cardiovascular disease using aptasensors: A review
по: Sara Ranjbari, и др.
Опубликовано: (2023-12-01)